BioSpace News Archive

StageZero Life Sciences, Ltd. announces that the Care Oncology Clinic service and COC Protocol is now available to patients living in Europe.

Solid Biosciences Inc. today provided an update from the ongoing IGNITE DMD Phase I/II clinical trial, as well as a business and financial update.

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the full year 2021 and provided a business update.

Theralink Technologies, a precision oncology molecular profiling company with a patented, novel phosphoprotein-based assay for breast cancer announced early results showing actionability and clinical utility for its commercial CLIA assay.

IQVIA Holdings Inc., a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, announced the appointment of Costa Panagos, to serve as president of its Research & Development Solutions business unit.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2021, with the U.S. Securities and Exchange Commission.

Increasing prevalence of cancer and reproductive health disorders and evolution of cutting-edge next-generation sequencing (NGS) platforms are among the key factors expected to drive the global market revenue growth.

According to Precedence Research, the global clinical workflow solutions market size is expected to reach around US$ 23.99 billion by 2030 from valued at USD 8.26 billion in 2021 with a CAGR of 12.6% from 2021 to 2030.

The global digital health market size is expected to be worth around US$ 551.09 billion by 2027 and poised to grow at a CAGR 16.5% from 2022 to 2027, according to Precedence Research.

According to Precedence Research, the global medical devices market is predicted to hit US$ 671.49 billion by 2027 and growing at a CAGR of 5.2% over the forecast period 2022 to 2027.